ijo
www.spandidos-publications.com
Home  | About  | Contact
Spandidos Logo
Advanced Search
Login  | Register


congress_banner

main_table_top_image
   Current Issue Early Online Archive Manuscript Submission About Editor and Editorial Academy Sitemap
Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor α-mediated transcription

Authors:
Jing Zhu, Subrata Sen, Chongjuan Wei, Marsha L. Frazier

Affiliations:
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA

Doi:
10.3892/ijo_00000473

Pages:
39-48

Abstract:

Alternate splicing of the cyclin D1 gene gives rise to transcripts a and b which encode two protein isoforms cyclin D1a and cyclin D1b. Cyclin D1a can substitute for estrogen to activate estrogen receptor α- (ERα) mediated transcription and can induce the proliferation of estrogen responsive tissues. However, little is known about the biological role of cyclin D1b in transcriptional regulation. In this study, we determined that cyclin D1b is incapable of inducing ERα-mediated transcription because it fails to recruit steroid receptor coactivator-1 (SRC-1) to ERα. Moreover, cyclin D1b antagonizes cyclin D1a-induced ERα-mediated transcription by competing with cyclin D1a for ERα binding. Cell proliferation assay showed that cyclin D1b repressed the ERα-positive breast cancer T47D cell growth. Our findings suggest that the cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on ERα-mediated transcription.

OPEN ACCESS ARTICLE

International Journal of Oncology

January 2010
Volume 36 Number 1


Viewing options: Sign up for eToc alerts

Share this article:



main_table_bottom_image